Methods to effectively detect multi-locus genetic association are becoming increasingly relevant in the genetic dissection of complex trait in humans. Current approaches typically consider a limited number of hypotheses, most of which are related to the effect of a single locus or of a relatively small number of neighboring loci on a chromosomal region. We have developed a novel method that is specifically designed to detect genetic association involving multiple disease-susceptibility loci, possibly on different chromosomes. Our approach relies on the efficient discovery of patterns comprising spatially unrestricted polymorphic markers and on the use of appropriate test statistics to evaluate pattern-trait association. Power calculations using multi-locus disease models demonstrate significant gain of power by using this method in detecting multi-locus genetic association when compared to a standard single marker analysis method. When analyzing a Schizophrenia dataset, we confirmed a previously identified gene-gene interaction. In addition, a less conspicuous association involving different markers on the same two genes was also identified, implicating genetic heterogeneity.
Introduction
Genetic dissection of complex traits in humans has become a major focus in the biomedical research community [Lander, et al. 2001] as the majority of common diseases with significant public health impact fall in this category. It has been proposed that genome-wide association analysis may be the choice of deciphering the non-Mendelian inheritance mode of common diseases [Risch and Merikangas 1996] . However, up to now there have been limited successes with conventional association studies [Hugot, et al. 2001; Rioux, et al. 2001; Tavtigian, et al. 2001] , possibly due to the multifactorial nature of common diseases. Multi-locus genetic association analysis seems to provide increased power to detect multiple susceptibility loci even with moderate sample size [Longmate 2001 ], and thus might be an advantageous alternative for the genetic dissection of complex traits in humans.
Methods for multi-locus association analysis can be classified into two broad categories: local multi-locus genetic association analysis and global multi-locus genetic association analysis [Hoh and Ott 2003] . Methods for local multi-locus genetic association analysis, such as the haplotype-based association test [Puffenberger, et al. 1994; Terwilliger and Ott 1992] and the haplotype-based Transmission Disequilibrium Test (TDT) [Clayton and Jones 1999; Clayton 1999; Dudbridge, et al. 2000; Lazzeroni and Lange 1998; Merriman, et al. 1998; Zhao, et al. 2000] , usually analyze multiple nearby loci jointly. χ 2 test of independence is often used to evaluate statistical significance of potential association [Spielman, et al. 1993; Terwilliger and Ott 1992] .
More recently, a generalized T 2 test utilizing multiple markers was proposed as a more powerful alternative to χ 2 test for association [Xiong, et al. 2002] . Methods for global multi-locus genetic association analysis [Hoh and Ott 2003] , such as logistic regression [Cruickshanks, et al. 1992 ], sums of single-marker statistics [Hoh, et al. 2000 ], combinatorial partitioning [Nelson, et al. 2001] , and data mining [Czika, et al. 2001; Flodman, et al. 2001; Toivonen, et al. 2000] , focus instead on the detection of multiple disease susceptibility loci regardless of their chromosomal locations in the genome.
Except for the combinatorial partitioning method, existing global multi-locus association analysis methods are not designed to systematically search all possible combination of loci in order to identify potential marker-trait association. As a result, a particular combination of marker loci with significant association to a trait might evade significance evaluation and go undetected.
Several challenges exist for developing such a method for global multi-locus association analysis. The foremost challenge arises from the combinatorial nature of the problem. Increasing the number of loci used in a genome-wide scan results in the exponential growth of possible multi-locus combinations, thus making the computational cost of their enumeration prohibitive. The second challenge is how to adjust statistical significance for multiple-testing. With tens of millions of multi-locus combinations evaluated and with strong correlations among different combinations due to locus sharing, proper multiple-testing corrections other than the Bonferroni correction are needed to control type I error while retaining power.
Pattern discovery-based approaches have been shown to be rather efficient at dealing with the combinatorial nature of identifying multi-element associations with analyses of protein motifs and gene expression data [Califano 2000; Rigoutsos and Floratos 1998 ]. Remarkably, a "Market Basket Analysis" (MBA) method, similar to the pattern discovery-based methods on sequence analysis and gene expression analysis, has been widely used in marketing research to identify association rules among disjointed sets of items [Agrawal and Srikant 1994] .
We have developed a pattern discovery-based method to detect both local and global multi-locus genetic associations. The method employs an efficient pattern discovery algorithm and a pattern-trait association test to assess the statistical significance of potential associations. A model to correct pattern significance for multiple testing was also developed. In this report, we have applied the pattern discovery-based method to both simulated datasets and a real Schizophrenia dataset. Power calculations using multi-locus disease models on simulated genotypes on 71 SNP markers demonstrated significant gain of power by using this method in detecting multi-locus genetic associations when compared to a standard single marker analysis method. When analyzing a Schizophrenia dataset, we not only confirmed the original finding of a genegene interaction associated with Schizophrenia [Chumakov, et al. 2002] , but also identified a potential association involving different alleles on the same two genes that had eluded previous detection efforts. Further analysis of this finding implies potential genetic heterogeneity. To summarize, our results indicated that the pattern discoverybased method for detecting multi-locus genetic association could be a useful tool for dissecting complex genetic traits in humans, particularly when oligogenic/polygenic inheritance and gene-gene interactions are present.
Materials

Two-Locus Disease Models
In this report, two-locus disease models [Clerget-Darpoux and Babron 1989; Dizier, et al. 1994; Fan and Knapp 2003; Xiong, et al. 2002] were chosen for power calculations (Table 1) . Each disease-causing locus was represented by a bi-allelic marker (marker M1
for the first locus, marker M2 for the second locus). In the recessive-recessive (R-R) model, the presence of homozygote genotypes in both markers (aa for M1, bb for M2) was required to confer the disease state (genotype aabb has elevated disease penetrance).
In the dominant-recessive (D-R) model, homozygote status was only required for marker M1 (both genotypes aaBb and aabb have elevated disease penetrance). To emulate the genetic complexity of common disease, we selected a high level of penetrance for phenocopies and modest penetrance for disease-causing genotype(s) [Gardner, et al. 1997; Lander and Schork 1994; Wallace, et al. 1996; Xiong, et al. 2002] . The penetrance of phenocopies (individuals that are affected but do not have the disease genotype(s) on M1 and M2) was set to 10%, while the penetrance of affected genotype was set to 26.4%
for the D-R model and 44% for the R-R model.
The rest of the 20 markers are on 13q34, spanning 266 kb and covering the G72[MIM607408] gene [Chumakov, et al. 2002] .
Simulated Data
Simulated genotype data were used for power calculation. Genotype data (without phase information) on 71 SNP markers were modeled after an actual human population [Johnson, et al. 2001] . In particular, 69 SNP markers on five genes were picked to serve as disease-unrelated markers (13 markers for gene H19, 11 markers for CASP10, 13 markers for CASP8, 20 markers for SDF1, and 12 markers for TCF8). Two additional markers (M1 and M2) were embedded into each simulated genome, serving as the disease-related markers.
Assuming a population-based case-control study design, genotype data were generated de novo from a simulation program (Dahlia Nielsen, personal communication) by providing values for the following program parameters: haplotype/allele frequencies, penetrance of disease-causing genotypes, and penetrance of phenocopies. Phase information and haplotype structures were ignored in data analysis. For each of the two disease models tested, we evaluated five genotype frequency settings for disease-related markers M1 and M2 (Table 1) and two sample sizes (250 cases/250 controls, and 500 cases/500 controls).
For each simulation condition, which was a combination of disease model, frequency setting, and sample size, 500 simulated datasets, each containing genotypes of 71 SNP markers, were generated. To derive test rejection level for individual pattern/marker, 500 simulated datasets were also generated for each simulation condition under the null hypothesis, in which the penetrance of phenocopies was used for all possible genotypes.
Methods and Results
Methods
The pattern discovery-based method for multi-locus genetic association analysis
Detailed notations on pattern and maximal patterns can be found in Appendix. Briefly, a pattern is a sub-matrix π of a data matrix M (individuals as rows and markers as columns), identified by a subset of the markers C π (pattern composition) and a subset of individuals S π (pattern support), such that the value of each marker X in π across the individuals within S π satisfies a predefined equivalence criteria. 
Power calculation
Different procedures were used to estimate power for the pattern discovery-based method and for the single marker χ 2 test. For the pattern discovery-based method, power was first calculated as a function of the pattern support constraint min j . Specifically, under each simulation condition the following procedure was used: At each value j of min j within an arbitrary window, typically between 20% and 40% of the case sample size, pattern discovery was performed on each of the 500 datasets. Resulting patterns identified at each j were assigned P values using the corresponding reference distribution D j and were deemed "significant" if their P values were less than j α . A true positive call was registered for a dataset if the pattern with only the disease genotypes for markers M1 and M2 was found significant. Power was defined as the percentage of true positive calls for a given value j of min j among all 500 datasets. The maximal power achieved under all values of min j was used as the representative power for the pattern discovery-based method under that particular simulation condition.
For the single marker χ 2 test, the set of markers with P value less than 0 α was selected. If both markers M1 and M2 were in that set, the test on that dataset was considered a true positive. The overall power of the single marker χ 2 test was again defined as the percentage of the true positive calls. 
-Based Single Marker Association Test
For the purpose of comparison, a χ 2 -based single marker association test was performed both to assess the statistical power of the approach based on simulated data and in the analysis of a Schizophrenia data set. In the test, a 2x2 [Chumakov, et al. 2002] . In [Chumakov, et al. 2002] , χ 2 test was performed separately in French Canadian and Russian populations. In this analysis, χ 2 test was performed on the combined population.)
Results
Estimation of Test Rejection Level for Individual Marker/Pattern
Before estimating power, test rejection level for individual marker or pattern was established from genotype data simulated on 71 markers under the null hypothesis. The null hypothesis was simulated under two different sample sizes (250 cases/250 controls and 500 cases/500 controls) and ten genotype frequencies for marker M1 and M2 (five genotype frequencies as in the D-R model and five as in the R-R model). Test rejection levels for individual marker and pattern were obtained at each value j of min j between 20% and 40% of the case sample size. Table 2 shows the mean test rejection levels for single marker and pattern with min j set to 20% of the case sample size. For the single marker χ 2 test, test rejection levels are fairly consistent across different simulation conditions. The single marker test rejection levels under both sample sizes (P=1.01E-3 and P=1.08E-3 for 250 cases and 500 cases, respectively) were less conservative than the Bonferroni correction, which would yields a significance level of 7.2E-4, presumably due to haplotype structures embedded in the simulation model. Similar observations were made on the test rejection level for single pattern with min j set to 20% of the case sample size (P=1.19E-4 and P=1.05E-4 for 250 cases and 500 cases, respectively). With on average 4,000 patterns identified from each simulated dataset with min j set to 20% of the case sample size, Bonferroni correction would have yielded a significant threshold of 1.25E-5. Because no clear power peak was visible for two of the smallest frequencies (5.1% and 9.1% for D-R, 2.9% and 5.1% for R-R) of affected genotypes under both disease models and both sample sizes, we further reduced min j to 10% of the case sample size to examine the possibility that larger power can be recovered with smaller min j . Indeed larger power was obtained in all eight simulation conditions, resulting in new for each condition (Table 3 , rows 1, 2, 6, and 7). The best power identified under each simulation condition optimal j (Table 3) was used for power comparison between the pattern discovery-based method for association analysis and the single marker χ 2 test (Figure 3 ).
Power Calculation and Comparison
Under all 20 simulation conditions, the pattern discovery-based methods consistently outperformed the single marker χ 2 test in terms of absolute power ( Figure   3A and 3C). While power for both methods improved with the larger sample size (500 vs.
250) and higher affected genotype frequency, the gain of power by the pattern discoverybased method over the single marker association test is not uniform ( Figure 3B and 3D) .
Instead, the pattern discovery-based method exhibited the largest gain of power when the affected genotype frequency was the smallest. For example, a more than 10 fold power increase over the single marker association test at affected genotype frequency of 5.1%
was observed for the pattern discovery-based method for the D-R disease model with 500
cases and 500 controls ( Figure 3B ). In the R-R disease model, a 27 fold power increase at affected genotype frequency of 2.9% was observed with 250 cases and 250 controls. On the other hand, there were less than 2 fold increases of power by the pattern discoverybased method over the single marker association test with affected genotype frequencies of 28% for the D-R model and of 15.6% for the R-R model. Differential power gain by the pattern discovery-based method over the single marker test was also observed at two sample sizes tested. As shown in Figure 3B and 3D, except for the simulation condition with affected genotype frequency of 5.1% in the D-R model, larger power ratios between these two methods were consistently observed with the sample size of 250 cases and 250 controls in comparison with the sample size of 500 cases and 500 controls. Taking together, these observations indicate that the pattern discovery-based method is able to detect disease association under all designed simulation conditions and might have significant advantage over the traditional single marker association test when the affected genotype frequency is small.
Detecting Gene-Gene Interactions in a Schizophrenia Dataset
In order to further assess the utility of the pattern discovery-based method for association analysis, we applied it to a well-characterized dataset collected from a case/control association study on Schizophrenia. The dataset contained genotypes for 28 SNP markers spanning 115 kb at 12q24 (8 markers) and 266 kb at 13q34 (20 markers). Using traditional association tests and functional assays, two interacting susceptibility genes were previously identified on these regions of the human genome [Chumakov, et al. 2002] : G72 on chromosome 13, and D-amino acid oxidase (DAO) on chromosome 12.
Specifically, markers M-22 on chromosome 13 and MDAAO-6 on chromosome 12 were found to show significant association with the disease when considered together. Because markers in this dataset are distributed over two different chromosomal regions and the associated markers are known, this dataset is ideal to test the pattern discovery-based method for multi-locus genetic association.
To establish a baseline, we used a frequency-based single-marker χ 2 test to detect genotype distribution bias in the dataset, similar to what was described [Chumakov, et al. 2002] . Consistent with previous findings [Chumakov, et al. 2002] , three markers were found to be statistically significant (P <= 0.01) with the single marker association test before multiple-testing correction (MDAAO-6: P=9.62e-4; M-22: P=5.84e-3; MDAAO-5: P=7.71e-3). With Bonferroni correction for multiple-testing to achieve a family-wise type I error of 0.05 (test rejection level for individual marker is 0.00183), however, only MDAAO-6 remained significant.
The pattern discovery-based method was applied to both the real dataset and 5,000 simulated datasets. Because the true statistical power for this method on this real dataset is unknown, we used the number of significant patterns as a representation of power to estimate the value of the optimal support constraint (the Appendix).
was estimated to be 24, roughly 10% of the case population under study ( The most significant pattern (Pattern A in Table 4A ) included two markers, marker MDAAO-6 on chromosome 12, and M-22 on chromosome 13, the same two markers that were previously identified in a multi-locus association with Schizophrenia [Chumakov, et al. 2002] . Relative risk analysis using a Crude Odds Ratio test [Hennekens and Buring 1987] on pattern A provided additional support to the significance of the association (Table 4A , odds ratio=4.54, confidence interval: 2.3-9.1).
The second significant pattern (Pattern B in Table 4A) (Table 4A ). The significance of the association was only found when they were considered together in a single pattern (P=7.33e-5). Again, crude odds ratio analysis indicated that pattern B carried significant relative risk for Schizophrenia (odds ratio=15, 95% confidence internal: 3.5-65).
Despite the fact that marker M-22 and markers M-11~M-16 are co-localized in a 266 kb region on chromosome 13, they belong to different LD blocks: Markers M-12~M-16 form a single LD block (D' between markers >0.9), while M-22 is in a LD block with M-23 and M-24 [Chumakov, et al. 2002] . Similarly, though barely 9.7 kb apart, markers MDAAO-6 and MDAAO-7 are not in strong linkage disequilibrium (D'=0.55).
Combined with the fact that markers in both patterns were mapped to the same two genes (DAO and G72), these observations prompted us to ask the following question: Do those two patterns indicate independent patterns of co-segregation, perhaps due to genetic heterogeneity? If that was the case, one would expect that the affected individuals carrying the MDAAO-6/M-22 mutations would be relatively disjoint from the affected individuals carrying the M-11~M-16/MDAAO-7 mutations. Indeed, when individuals participated in pattern A and B are tallied, only three cases and none of the controls participated in both patterns (Table 4B ). To calculate the combined relative risk on DAO and G72 loci as characterized by Pattern A or Pattern B for Schizophrenia, we constructed a χ 2 test (Table 4C) in which individuals carrying either of the two patterns or none of the two patterns were counted in cases and in controls. A significant P value (P=8.67E-11) suggested that at least two independent patterns of co-segregation might be responsible for the susceptibility on the DAO and G72 loci.
Discussion
The pattern discovery-based method for multi-locus genetic association has several novel properties. First, unlike current local multi-locus analysis methods [Lazzeroni and Lange 1998; Puffenberger, et al. 1994; Terwilliger and Ott 1992] , which are usually restricted to nearby markers, a pattern can contain markers located far apart on a chromosome or even on different chromosomes. It is, therefore, ideally suited for the identification of all possible co-segregations in the genome, which might be a powerful way to effectively locate multiple disease susceptibility genes responsible for common diseases. Second, comparing to other global multi-locus analysis methods such as the logistic regression analysis [Cruickshanks, et al. 1992 ] and the sum of single-marker statistics [Hoh, et al. 2000 ], our method does not rely on single-locus effects. Instead, it can detect both singlelocus and multi-locus effects simultaneously. Third, the deterministic nature of the algorithm guarantees the discovery of all maximal patterns, thus reducing the risk of missing important multi-locus association. The identification of the second significant association involving seven markers from the Schizophrenia dataset by the pattern discovery-based method supports this notion. Fourth, this approach is modelindependent and can be applied to various study designs such as case/control and familybased studies, making it a general method for genetic analysis.
One of the most significant challenges for the pattern discovery-based method is how to correct for multiple testing. For example, even a moderate sized dataset with a few hundred markers can produce tens of thousands of highly correlated patterns, Under two disease models we demonstrated that our pattern discovery-based multi-locus association test has superior power to detect multi-locus association when compared to a single marker association test. To properly generate simulation datasets, several assumptions reflecting the underlying genetic complexity of common diseases were implemented, including factors such as incomplete penetrance, polygenic inheritance, and high frequency of disease-causing alleles, etc.. In both disease models, polygenic inheritance was required for modestly elevated but partial disease penetrance.
A rather substantial (10%) penetrance for phenocopies was used. On those two markers representing the susceptibility loci, both affected alleles were common alleles with high allele frequencies (from 23% to 75%, depending on the disease model and simulation condition). By demonstrating strong power under these simulation conditions, we argue that the pattern discovery-based method is a valid approach for detecting associations of genetic factors to complex traits. Furthermore, simulations suggested that the pattern discovery-based method gained most power with relatively small sample sizes and low allele frequencies for associated allele.
The discovery of two significant patterns from the Schizophrenia dataset provided a good example to illustrate some of the advantages of using the pattern discovery-based method. Not only did our method confirmed original finding of a gene-gene interaction (Table 4 , pattern A) [Chumakov, et al. 2002] , it also detected a potential association (Table 4 , pattern B) that was not identified previously. Interestingly, none of the markers in pattern B was significant individually, only by analyzing all possible combinations of these markers were we able to identify the potential association. It is critical to confirm the genetic association suggested by pattern B with an independent dataset in future studies and with functional assays.
In summary, our analysis suggested that the pattern discovery-based method for multi-locus genetic association analysis is a potentially powerful test that can be applied to the dissection of complex genetic traits in humans. When compared to a standard single marker association test, the pattern discovery based method appears to have more power at detecting susceptibility loci, especially when multiple disease-causing genes are present. In order to use the method in genome-wide association studies, the efficiency of the pattern discovery algorithm needs to be improved so that tens of thousands of markers can be readily accommodated in a single search. At the present, a divide-and-conquer approach is designed to handle large dataset collected from genome-wide association studies. With proper heuristics, we hope to be able to reduce the search space for maximal patterns while retaining power. Removal from a pattern of one or more individuals (rows) and/or one or more markers (columns) will result in a new sub-matrix that is also a pattern. The latter will be In the context of a case/control study, we are seeking maximal patterns that exhibit a significantly higher support in the case versus the control group. Therefore, our method commences by a discovery step where maximal patterns are only identified in cases (the case-only approach), which is followed by significance evaluation through an association test statistics that accept or reject the null hypothesis of no distribution difference in the pattern support between cases and controls. Comparing to an alternative approach in which patterns are discovered in cases plus controls and then evaluated in cases against controls (the case+control approach), the case-only approach has the following advantages: (1 In the test statistic, a 2x2 contingency table is constructed with one column for cases and one for controls. Cells in the first row of the table register supports of a pattern in cases and in controls. Cells in the second row register the numbers of cases and controls that are genotyped on markers in a pattern but do not contain the pattern.
Appendix
Definitions
Alternatively, a 2xn contingency table can also be used with n-1 degree of freedom and with n observed genotype/allele combinations among markers in a pattern. A goodnessof-fit test similar to the χ 2 test is then performed. P values are derived from a reference distribution that is generated with a Monte Carlo permutation process. In the Monte Carlo process, typically 1,000~10,000 simulated datasets are synthesized by randomly picking cases from the pool of actual cases and controls. Pattern discovery is then performed on each simulated dataset with the same constraint parameters and min k min j used in actual dataset. A reference distribution is subsequently generated from tallies of test statistics obtained from each simulation.
One serious challenge for our approach is the multiple-testing problem. Even a moderate sized dataset with just a few hundred markers can contain tens of thousands of maximal patterns, many of which can be spurious associations. Although Bonferroni correction is routinely used to estimate the test rejection level for individual marker (α i )
so that the family-wise type I error (α) is controlled (normally to 5%), it is too conservative for patterns (as shown below in Results), because of extensive correlations among patterns due to marker sharing.
To properly estimate α i, , we again used outputs obtained from the Monte Carlo simulation process from which the reference distribution for test statistics is produced for a target dataset. Assuming the null hypothesis for all of the simulated datasets, a familywise type I error rate of 0.05 means that significant patterns appear in no more than 5% of the simulated datasets. Patterns were discovered within each simulated dataset and were assigned P values according to the reference distribution discussed above. The smallest P value from each dataset was ordered again in ascending order for all simulated datasets.
The largest P value at the top 5 percentile was declared the test rejection level for individual pattern.
In summary, on a dataset collected from a case-control study, the pattern discovery-based association test containing the following steps: (1) Maximal patterns are identified from the case dataset with properly chosen min j ; (2) Maximal patterns are evaluated for significant association using a goodness-of-fit statistical test under the null hypothesis that both cases and controls are from the same sample population. Pattern significance is adjusted for multiple-testing with simulation. column were obtained by averaging the rejection levels from each of 10 datasets generated using the simulation conditions described in the text. For the pattern discoverybased method, the values displayed are for support constraint min j equal to 20% of the size of the case group. The "x" marks indicate the marker composition for a pattern. A sample genotype data matrix with 9 SNP markers (M1~M9) on 8 individuals (I1~I8) was shown. Genotype is represented as two alleles. Cells corresponding to pattern A or B were color-coded. M1  M2  M3  M4  M5  M6  M7  M8  M9  I1 A 
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